Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Barraclough

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Translational Oncogenomics|May 7, 2013
Tetracycline regulated systems in functional oncogenomicsArkadiusz Welman, Jane Barraclough, Caroline Dive
Nature Protocols|April 5, 2007
Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2Arkadiusz Welman, Jane Barraclough, Caroline Dive
Neoplasia (New York, N.Y.)|September 28, 2007
Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cellsJane Barraclough, Cassandra Hodgkinson, Alison Hogg, et al.
Nature Reviews. Cancer|July 8, 2011
Cyclin D as a therapeutic target in cancerElizabeth A Musgrove, C Elizabeth Caldon, Jane Barraclough, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Difluoro analogue of UCS15A triggers activation of exogenously expressed c-Src in HCT 116 human colorectal carcinoma cellsNoor Atatreh, Jane Barraclough, Arkadiusz Welman, et al.
Neoplasia (New York, N.Y.)|November 30, 2006
Increases in c-Src expression level and activity do not promote the growth of human colorectal carcinoma cells in vitro and in vivoArkadiusz Welman, Christopher Cawthorne, Lourdes Ponce-Perez, et al.
Journal of Cellular Biochemistry|January 26, 2005
Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expressionArkadiusz Welman, Christopher Cawthorne, Jane Barraclough, et al.
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.
The FEBS Journal|July 24, 2013
Global characterization of signalling networks associated with tamoxifen resistance in breast cancerBrigid C Browne, Falko Hochgräfe, Jianmin Wu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Translational Oncogenomics|May 7, 2013
Tetracycline regulated systems in functional oncogenomicsArkadiusz Welman, Jane Barraclough, Caroline Dive
Nature Protocols|April 5, 2007
Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2Arkadiusz Welman, Jane Barraclough, Caroline Dive
Neoplasia (New York, N.Y.)|September 28, 2007
Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cellsJane Barraclough, Cassandra Hodgkinson, Alison Hogg, et al.
Nature Reviews. Cancer|July 8, 2011
Cyclin D as a therapeutic target in cancerElizabeth A Musgrove, C Elizabeth Caldon, Jane Barraclough, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Difluoro analogue of UCS15A triggers activation of exogenously expressed c-Src in HCT 116 human colorectal carcinoma cellsNoor Atatreh, Jane Barraclough, Arkadiusz Welman, et al.
Neoplasia (New York, N.Y.)|November 30, 2006
Increases in c-Src expression level and activity do not promote the growth of human colorectal carcinoma cells in vitro and in vivoArkadiusz Welman, Christopher Cawthorne, Lourdes Ponce-Perez, et al.
Journal of Cellular Biochemistry|January 26, 2005
Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expressionArkadiusz Welman, Christopher Cawthorne, Jane Barraclough, et al.
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.
The FEBS Journal|July 24, 2013
Global characterization of signalling networks associated with tamoxifen resistance in breast cancerBrigid C Browne, Falko Hochgräfe, Jianmin Wu, et al.
Pageof 1